Regulations research / FDA data / Drug shortages / Dexmedetomidine Hydrochloride Injection Drug shortages Dexmedetomidine Hydrochloride Injection Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Unavailable · Reason: Discontinuation of the manufacture of the drug
2026-10-14 Current 83634-600-02 Anesthesia
Open FDA's page for this record
Update type Revised
Initial posting date 04/10/2020
Package NDC 83634-600-02
Generic name Dexmedetomidine Hydrochloride Injection
Related info link https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Dexmedetomidine%20Hydrochloride%20Injection&st=d
Contact info See Related Information section below for customer service information
Availability Unavailable
Related info Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229
Update date 10/14/2026
Dosage form Injection
Presentation Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)
Company name Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Shortage reason Discontinuation of the manufacture of the drug
Status Current
Therapeutic category Anesthesia Harmonized identifiers (openFDA)
Application number ANDA209065
Brand name DEXMEDETOMIDINE
Generic name DEXMEDETOMIDINE
Manufacturer name Avenacy Inc.
Product NDC 83634-600
Product type HUMAN PRESCRIPTION DRUG
Route INTRAVENOUS
Substance name DEXMEDETOMIDINE HYDROCHLORIDE
RxCUI 309710
SPL ID f036291f-40af-44b9-8a7f-d4475788ea63
SPL set ID eee6145b-d83f-4596-92d3-733934d8a3a4
Package NDC 83634-600-41, 83634-600-02
UNII 1018WH7F9I Drug shortages Dexmedetomidine Hydrochloride Injection Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
2026-10-14 To Be Discontinued 83634-600-02 Anesthesia
Open FDA's page for this record
Discontinued date 10/14/2026
Update type New
Initial posting date 10/14/2026
Package NDC 83634-600-02
Generic name Dexmedetomidine Hydrochloride Injection
Contact info See Related Information section below for customer service information
Related info Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229
Update date 10/14/2026
Dosage form Injection
Presentation Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)
Company name Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Status To Be Discontinued
Therapeutic category Anesthesia Harmonized identifiers (openFDA)
Application number ANDA209065
Brand name DEXMEDETOMIDINE
Generic name DEXMEDETOMIDINE
Manufacturer name Avenacy Inc.
Product NDC 83634-600
Product type HUMAN PRESCRIPTION DRUG
Route INTRAVENOUS
Substance name DEXMEDETOMIDINE HYDROCHLORIDE
RxCUI 309710
SPL ID f036291f-40af-44b9-8a7f-d4475788ea63
SPL set ID eee6145b-d83f-4596-92d3-733934d8a3a4
Package NDC 83634-600-41, 83634-600-02
UNII 1018WH7F9I Wholesale access for licensed clinicians. Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.
Data from openFDA , FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.